← All Sponsors
SPONSOR

KU Leuven

Total Trials
3
Recruiting
3
Phases
Phase 2

KU Leuven is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Intensive Care Unit Acquired Weakness, Critical Illness, Parkinson Disease, Idiopathic, Freezing of Gait.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — KU Leuven

How many clinical trials has KU Leuven sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by KU Leuven, of which 3 are actively recruiting participants. These trials cover conditions including Intensive Care Unit Acquired Weakness, Critical Illness, Parkinson Disease, Idiopathic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does KU Leuven research focus on?
KU Leuven clinical trials span Intensive Care Unit Acquired Weakness, Critical Illness, Parkinson Disease, Idiopathic, Freezing of Gait, Validation, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a KU Leuven clinical trial?
To participate in a KU Leuven trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all KU Leuven trials with current recruitment status updated daily.

Clinical Trials by KU Leuven

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology